Krazati Tablet, Coated
Product Images NDC 80739-812

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Krazati (NDC 80739-812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mirati Therapeutics, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Krazati 01)

Chemical structure of adagrasib, the active ingredient in KRAZATI (adagrasib) 200 mg coated tablets. The structure depicts the molecular arrangement including rings, atoms, and bonds representative of adagrasib's chemical composition.*

FDA Label Image

Principal Display Panel (180 Tablet Bottle Carton)

Packaging label for KRAZATI 200 mg adagrasib tablets, oral coated tablets in a bottle of 180 tablets. Manufactured for Mirati Therapeutics, Inc., with NDC 80739-812-18. The label includes dosage strength, quantity, storage instructions, and a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.